Ειδήσεις: PHARMA | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 11:40 investing.com

Grifols shares rise as board approves U.S. Biopharma IPO to cut debt

Grifols IPO U.S. biopharma debt reduction stock market corporate finance

25/03 10:12 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Raised to $213.00 at Bank of America

Insmed price target Bank of America Royal Bank of Canada Citigroup HC Wainwright

25/03 09:51 investing.com

Aptamer Group reports 27% revenue growth on pharma contracts

Aptamer Group revenue growth pharma contracts biotechnology drug discovery 27%

25/03 09:36 defenseworld.net

Leerink Partners Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price

Insmed Leerink Partners price target outperform rating mixed analyst views biopharmaceutical

25/03 09:35 defenseworld.net

Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A.

Amneal Pharmaceuticals Assenagon Asset Management Q4 holdings 13F filing hedge fund stock purchase

25/03 08:37 defenseworld.net

Head to Head Contrast: Eagle Pharmaceuticals (NASDAQ:EGRX) and Innovus Pharmaceuticals (OTCMKTS:INNVD)

Eagle Pharmaceuticals Innovus Pharmaceuticals valuation revenue earnings per share price‑to‑earnings ratio

25/03 08:09 defenseworld.net

BioPharma Credit (LON:BPCP) Shares Down 0.2% – Time to Sell?

BioPharma Credit share price investment trust royalty‑secured debt market cap beta

25/03 08:06 defenseworld.net

Xencor’s (XNCR) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

Xencor JPMorgan neutral rating price objective biopharma analyst coverage

25/03 07:26 defenseworld.net

Connect Biopharma (NASDAQ:CNTB) and BioMarin Pharmaceutical (NASDAQ:BMRN) Financial Comparison

Connect Biopharma BioMarin Pharmaceutical institutional ownership valuation insider holdings dividends

25/03 07:26 defenseworld.net

Connect Biopharma (NASDAQ:CNTB) and BioMarin Pharmaceutical (NASDAQ:BMRN) Financial Comparison

Connect Biopharma BioMarin Pharmaceutical institutional ownership valuation insider holdings dividends

Loading...